The decreased percentage of CD14++CD16− monocytes in parallel to an increased percentage of CD14++CD16+ and CD14+CD16++ monocytes in HD patients compared to controls (Fig. 1) suggests that CD14++CD16− monocytes differentiate toward CD14++CD16+ and CD14+CD16++15. This evidence concerns the gene CD14 and Huntington disease.